Science
Science|MGK
MGK Announces Leadership Transition; Randy Nelson to Succeed Steve Gullickson
MGK, a trusted provider of insect control solutions, today announced that Steve Gullickson, President of the Environmental Health Division of Sumitomo Biorational Company, will step down from his role effective December…
October 20, 2026 · 5:53 PM
Science
TriSalus Life Sciences to Host Third Quarter 2026 Financial Results Conference Call
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard-of-care therapies and an investigational immunotherapeutic to transform outcomes for pa…
October 20, 2026 · 4:32 PM
Science
Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will…
October 20, 2026 · 4:30 PM
Science
Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
Mirion, a leading provider of advanced radiation safety solutions, has announced support for the International Atomic Energy Agency (IAEA) Rays of Hope initiative, which aims to help address disparities in access to qual…
October 20, 2026 · 4:18 PM
Science
AN2 Therapeutics to Participate at Upcoming Investor Conferences
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced company management…
October 20, 2026 · 4:13 PM
Science|GeneDx
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its genome testing portfolio with long-read whole genome sequencing (lrW…
October 20, 2026 · 4:05 PM
Science|Vertex
Vertex Appoints Daniel Brennan to its Board of Directors
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Daniel Brennan has been appointed to its Board of Directors as an independent director. Mr. Brennan has more than 35 years of experience in finance…
October 20, 2026 · 4:05 PM
Science
Laxxon Medical to Participate in the Jefferies Global Healthcare Conference
Laxxon Medical Corp. (“Laxxon Medical” or the “Company”), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs) technology, today…
October 20, 2026 · 4:01 PM
Science|Bruker
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2026 financial results before market opening on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 8:30 a.m.…
October 20, 2026 · 4:01 PM
Science
101 Therapeutics to Present Phase 2/3 Data on Macrophage-Targeted, Steroid-Sparing Glucocorticoid 101-PGC-005 at ACR Convergence 2026
CD206-targeted glucocorticoid 101-PGC-005 beat dexamethasone in 309-patient Phase 2/3 trial (HR 2.31); steroid-sparing data at ACR Poster 0122, Nov 8...
October 20, 2026 · 2:46 PMLatest from leading organizations
Explore recent announcements by organization
